Log In
Print
BCIQ
Print
Print this Print this
 

PT005

  Manage Alerts
Collapse Summary General Information
Company Pearl Therapeutics Inc.
DescriptionFormoterol fumarate, a long-acting adrenergic receptor beta 2 agonist (LABA) delivered via a metered-dose hydrofluoroalkane (HFA) inhaler
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Latest Stage of DevelopmentPhase III
IndicationChronic obstructive pulmonary disease (COPD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today